Professor Philip Sambrook

Professor
Medicine, Northern Clinical School

E25 - Royal North Shore Hospital
The University of Sydney
NSW 2006 Australia

T:+61 2 9926 7281
F:+61 2 9906 1859
E:

Publications

2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003

2009

  
  • Chen, J., Sambrook, P., Simpson, J., Cameron, I., Cumming, R., Seibel, M., Lord, S., March, L. Risk factors for hip fracture among institutionalised older people. Age and Ageing. 2009; 38:429-434. [Abstract]
  • Anandacoomarasamy, A., Giuffre, B., Leibman, S., Caterson, I., Smith, G., Fransen, M., Sambrook, P., March, L. Delayed gadolinium-enhanced magnetic resonance imaging of cartilage: clinical associations in obese adults. Journal of Rheumatology. 2009; 36:1056-1062. [Abstract]
  • Xue, M., Smith, M., Little, C., Sambrook, P., March, L., Jackson, C. Activated Protein C Mediates a Healing Phenotype In Cultured Tenocytes. Journal of cellular and molecular medicine. 2009; 13:749-57. [Abstract]
  • Cumming, R., Handelsman, D., Seibel, M., Creasey, H., Sambrook, P., Waite, L., Naganathan, V., Couteur, D., Litchfield, M. Cohort profile: The Concord Health and Ageing in Men Project (CHAMP). International journal of epidemiology. 2009; 38:374-8. [Abstract]
  • Chen, J., Hogan, C., Lyubomirsky, G., Sambrook, P. Management of osteoporosis in primary care in Australia. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2009; 20:491-6. [Abstract]
  • Makovey, J., Chen, J., Hayward, C., Williams, F., Sambrook, P. Association between serum cholesterol and bone mineral density. Bone. 2009; 44:208-13. [Abstract]
  • Chen, J., March, L., Cumming, R., Cameron, I., Simpson, J., Lord, S., Sambrook, P. Role of quantitative ultrasound to predict fracture among institutionalised older people with a history of fracture. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2009; 20:105-12. [Abstract]
  • Sambrook, P. Consensus practice guidelines for bisphosphonate-associated osteonecrosis of the jaw. Nature clinical practice. Rheumatology. 2009; 5:6-7. [Abstract]

2008

  
  • Blyth, F., Rochat, S., Cumming, R., Creasey, H., Handelsman, D., Couteur, D., Naganathan, V., Sambrook, P., Seibel, M., Waite, L. Pain, frailty and comorbidity on older men: The CHAMP study. Pain. 2008; 140:224-30. [Abstract]
  • Whitmont, K., Reid, I., Tritton, S., March, L., Xue, M., Lee, M., Fulcher, G., Sambrook, P., Slobedman, E., Cooper, A., Jackson, C. Treatment of chronic leg ulcers with topical activated protein C. Archives of Dermatology. 2008; 144:1479-1483. [Abstract]
  • Chen, J., Simpson, J., March, L., Cameron, I., Cumming, R., Lord, S., Seibel, M., Sambrook, P. Risk Factors for Fracture Following a Fall Among Older People in Residential Care Facilities in Australia. Journal of the American Geriatrics Society. 2008; 56:2020-6. [Abstract]
  • Chen, J., Simpson, J., March, L., Cameron, I., Cumming, R., Lord, S., Seibel, M., Sambrook, P. Fracture risk assessment in frail older people using clinical risk factors. Age and ageing. 2008; 37:536-41. [Abstract]
  • Bianchi, G., Sambrook, P. Oral nitrogen-containing bisphosphonates: a systematic review of randomized clinical trials and vertebral fractures. Current medical research and opinion. 2008; 24:2669-2677. [Abstract]
  • Delbaere, K., Close, J., Menz, H., Cumming, R., Cameron, I., Sambrook, P., March, L., Lord, S. Development and validation of fall risk screening tools for use in residential aged care facilities. The Medical Journal of Australia. 2008; 189:193-196. [Abstract]
  • Jackson, C., Whitmont, K., Tritton, S., March, L., Sambrook, P., Xue, M. New therapeutic applications for the anticoagulant, activated protein C. Expert Opinion on Biological Therapy. 2008; 8:1109-1122. [Abstract]
  • Geusens, P., Roux, C., Reid, D., Lems, W., Adami, S., Adachi, J., Sambrook, P., Saag, K., Lane, N., Hochberg, M. Drug Insight: choosing a drug treatment strategy for women with osteoporosis-an evidence--based clinical perspective. Nature clinical practice. Rheumatology. 2008; 4:240-248. [Abstract]
  • Anandacoomarasamy, A., Bagga, H., Ding, C., Burkhardt, D., Sambrook, P., March, L. Predictors of clinical response to intraarticular Hylan injections -- a prospective study using synovial fluid measures, clinical outcomes, and magnetic resonance imaging. The Journal of Rheumatology. 2008; 35:685-690. [Abstract]
  • Sambrook, P., Ebeling, P. Osteonecrosis of the jaw. Current Rheumatology Reports. 2008; 10:97-101. [Abstract]
  • Chen, J., Sambrook, P., March, L., Cameron, I., Cumming, R., Simpson, J., Seibel, M. Hypovitaminosis D and parathyroid hormone response in the elderly: effects on bone turnover and mortality. Clinical endocrinology. 2008; 68:290-8. [Abstract]
  • Anandacoomarasamy, A., Caterson, I., Sambrook, P., Fransen, M., March, L. The impact of obesity on the musculoskeletal system. International journal of obesity (2005). 2008; 32:211-22. [Abstract]
  • Sanchez Riera, L., Wilson, N., Sambrook, P., Kok, C., Cumming, R., Cameron, I., Chen, J., Simpson, J., Mason, R., Seibel, M., March, L. Trends in calcium and vitamin D usage among older people in nursing care facilities in Australia: still falling short of the guidelines. International Journal of Rheumatic Diseases. 2008; 11:430-434.

2007

  
  • Xue, M., March, L., Sambrook, P., Fukudome, K., Jackson, C. Endothelial protein C receptor is over-expressed in rheumatoid arthritic (RA) synovium and mediates the anti-inflammatory effects of activated protein C in RA monocytes. Annals of the rheumatic diseases. 2007; 66:1574-80. [Abstract]
  • Sambrook, P. Anabolic Therapy in Glucocorticoid-Induced Osteoporosis. The New England journal of medicine. 2007; 357:2084-2086. [Abstract]
  • Makovey, J., Nguyen, T., Naganathan, V., Wark, J., Sambrook, P. Genetic effects on bone loss in peri- and postmenopausal women: a longitudinal twin study. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2007; 22:1773-1780. [Abstract]
  • Xue, M., March, L., Sambrook, P., Jackson, C. Differential regulation of matrix metalloproteinase 2 and matrix metalloproteinase 9 by activated protein C: Relevance to inflammation in rheumatoid arthritis. Arthritis and rheumatism. 2007; 56:2864-74. [Abstract]
  • Sambrook, P., Cameron, I., Chen, J., Cumming, R., Lord, S., March, L., Schwarz, J., Seibel, M., Simpson, J. Influence of fall related factors and bone strength on fracture risk in the frail elderly. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2007; 18:603-10. [Abstract]
  • Makovey, J., Naganathan, V., Seibel, M., Sambrook, P. Gender differences in plasma ghrelin and its relations to body composition and bone - an opposite-sex twin study. Clinical endocrinology. 2007; 66:530-537. [Abstract]
  • Sambrook, P. Are bisphosphonates more effective than vitamin D3 analogs for the prevention of glucocorticoid-induced osteoporosis?. Nature clinical practice. Endocrinology & metabolism. 2007; 3:206-207. [Abstract]
  • Naganathan, V., MacGregor, A., Sambrook, P. The role of gene-environment interaction in determining bone mineral density in a twin population. Twin research and human genetics : the official journal of the International Society for Twin Studies. 2007; 10:191-197. [Abstract]
  • Sambrook, P. Tumour necrosis factor blockade and the risk of osteoporosis: back to the future. Arthritis research & therapy. 2007; 9:107. [Abstract]
  • Sambrook, P. Quarterly intravenous injection of ibandronate to treat osteoporosis in postmenopausal women. Clinical interventions in aging. 2007; 2:65-72. [Abstract]

2006

  
  • Sambrook, P. Preface. Rheumatic diseases clinics of North America. 2006; 32:xi-xii. [Abstract]
  • Combe, B., Codreanu, C., Fiocco, U., Gaubitz, M., Geusens, P., Kvien, T., Pavelka, K., Sambrook, P., Smolen, J., Wajdula, J., Fatenejad, S., , E. Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparison. Annals of the rheumatic diseases. 2006; 65:1357-62. [Abstract]
  • Chen, J., Seibel, M., Zochling, J., March, L., Cameron, I., Cumming, R., Schwarz, J., Simpson, J., Sambrook, P. Calcaneal Ultrasound but Not Bone Turnover Predicts Fractures in Vitamin D Deficient Frail Elderly at High Risk of Falls. Calcified tissue international. 2006; 79:37-42. [Abstract]
  • Sambrook, P., Cooper, C. Osteoporosis. Lancet. 2006; 367:2010-8. [Abstract]
  • Delmas, P., Adami, S., Strugala, C., Stakkestad, J., Reginster, J., Felsenberg, D., Christiansen, C., Civitelli, R., Drezner, M., Recker, R., Bolognese, M., Hughes, C., Masanauskaite, D., Ward, P., Sambrook, P., Reid, D. Intravenous ibandronate injections in postmenopausal women with osteoporosis - One-year results from the dosing intravenous administration study. Arthritis and Rheumatism. 2006; 54:1838-1846. [Abstract]
  • Bagga, H., Burkhardt, D., Sambrook, P., March, L. Longterm effects of intraarticular hyaluronan on synovial fluid in osteoarthritis of the knee. The Journal of rheumatology. 2006; 33:946-50. [Abstract]
  • Sambrook, P., Chen, C., March, L., Cameron, I., Cumming, R., Lord, S., Simpson, J., Seibel, M. High bone turnover is an independent predictor of mortality in the frail elderly. Journal of bone and mineral research. 2006; 21:549-555. [Abstract]
  • Sambrook, P. Compliance with treatment in osteoporosis patients--an ongoing problem. Australian family physician. 2006; 35:135-7. [Abstract]
  • Wilson, S., Adam, G., Langdown, M., Reneland, R., Braun, A., Andrew, T., Surdulescu, G., Norberg, M., Dudbridge, F., Reed, P., Sambrook, P., Kleyn, P., Spector, T. Linkage and potential association of obesity-related phenotypes with two genes on chromosome 12q24 in a female dizygous twin cohort. European journal of human genetics : EJHG. 2006; 14:340-8. [Abstract]
  • Chen, J., Cameron, I., Cumming, R., Lord, S., March, L., Sambrook, P., Simpson, J., Seibel, M. Effect of age-related chronic immobility on markers of bone turnover. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2006; 21:324-31. [Abstract]
  • Sutcliffe, A., Spoudeas, H., Nair, D., Bouloux, P., Oliver, T., Sambrook, P., Bannister, W., Lambalk, C., Spector, T. Comparison of serum FSH and Inhibin B levels between adult male dizygotic and monozygotic twins. Human reproduction (Oxford, England). 2006; 21:447-50. [Abstract]
  • Sambrook, P. Selective estrogen receptor modulators (SERMs). In: Osteoporosis and the Osteoporosis of Rheumatic Diseases. Philadelphia: Mosby Elsevier 2006. p. 141-144.
  • Xue, M., Thompson, P., Sambrook, P., March, L., Jackson, C. Activated protein C stimulates expression of angiogenic factors in human skin cells, angiogenesis in the chick embryo and cutaneous wound healing in rodents. Clinical hemorheology and microcirculation. 2006; 34:153-61. [Abstract]
  • Sambrook, P., Lane, N. Corticosteroid-induced osteoporosis. In: Osteoporosis and the Osteoporosis of Rheumatic Diseases. Philadelphia: Mosby Elsevier 2006. p. 215-220.
  • Sambrook, P. Vitamin D and its metabolites in the prevention and treatment of osteoporosis. In: Osteoporosis and the Osteoporosis of Rheumatic Diseases. Philadelphia: Mosby Elsevier 2006. p. 131-139.

2005

  
  • Sambrook, P. Who will benefit from treatment with selective estrogen receptor modulators (SERMs)?. Best practice & research. Clinical rheumatology. 2005; 19:975-81. [Abstract]
  • Petty, S., Paton, L., O'Brien, T., Makovey, J., Erbas, B., Sambrook, P., Berkovic, S., Wark, J. Effect of antiepileptic medication on bone mineral measures. Neurology. 2005; 65:1358-65. [Abstract]
  • Zochling, J., Chen, J., Seibel, M., Schwarz, J., Cameron, I., Cumming, R., March, L., Sambrook, P. Calcium metabolism in the frail elderly. Clinical rheumatology. 2005; 24:576-82. [Abstract]
  • Sambrook, P., Schacht, E. Introduction. D-hormones alfacalcidol and calcitriol for prevention and treatment of glucocorticoid/inflammation-induced osteoporosis. The Journal of rheumatology. Supplement. 2005; 76:1-3. [Abstract]
  • Sambrook, P. D-hormones for prevention of bone loss after organ transplant. The Journal of rheumatology. Supplement. 2005; 76:41-3. [Abstract]
  • Hien, L., Cumming, R., Cameron, I., Chen, J., Lord, S., March, L., Schwarz, J., Le Couteur, D., Sambrook, P. Atypical antipsychotic medications and risk of falls in residents of aged care facilities. Journal of the American Geriatrics Society. 2005; 53:1290-5. [Abstract]
  • Sambrook, P., Makovey, J., Naganathan, V., Seibel, M. Gender differences in serum leptin and ghrelin: Relationship to body composition and bone mineral measures - A cross-sectional opposite sex twin study. Bone. 2005; 36:S382-S382. [Abstract]
  • Delmas, P., Khaltaev, N., Arriagada, M., Brandi, M., Cannata, J., Lau, E., Lederman, R., Lorenc, R., Minne, H., Morales-Torres, J., Morii, H., Sambrook, P., Torralba, T., Zanchetta, J., Reginster, J. Editorial. The Journal of Musculoskeletal and Neuronal Interactions. 2005; 5:105-9. [Abstract]
  • Seibel, M., Chen, C., March, L., Cameron, I., Cumming, R., Simpson, J., Sambrook, P. High bone turnover is an independent predictor of mortality in the frail elderly: A prospective cohort study. Bone. 2005; 36:S146-S147. [Abstract]
  • Sambrook, P., Chen, C., March, L., Cameron, I., Cumming, R., Lord, S., Seibel, M. Low bone turnover and functional hypoparathyroidism reduce mortality in vitamin D deficient elderly. Bone. 2005; 36:S145-S146. [Abstract]
  • Chen, C., Sambrook, P., March, L., Cameron, I., Cumming, R., Simpson, J., Seibel, M. Immobility is associated with high bone turnover in the frail elderly. Bone. 2005; 36:S332-S332. [Abstract]
  • Chen, J., March, L., Schwarz, J., Zochling, J., Makaroff, J., Sitoh, Y., Lau, T., Lord, S., Cameron, I., Cumming, R., Sambrook, P. A multivariate regression model predicted falls in residents living in intermediate hostel care. Journal of clinical epidemiology. 2005; 58:503-8. [Abstract]
  • Diamond, T., Eisman, J., Mason, R., Nowson, C., Pasco, J., Sambrook, P., Wark, J. Vitamin D and adult bone health in Australia and New Zealand: a position statement. Medical Journal of Australia. 2005; 182:281-285. [Abstract]
  • Reneland, R., Mah, S., Kammerer, S., Hoyal, C., Marnellos, G., Wilson, S., Sambrook, P., Spector, T., Nelson, M., Braun, A. Association between a variation in the phosphodiesterase 4D gene and bone mineral density. BMC medical genetics [electronic resource]. 2005; 6:9. [Abstract]
  • Sitoh, Y., Lau, T., Zochling, J., Schwarz, J., Chen, J., March, L., Cumming, R., Lord, S., Sambrook, P., Cameron, I. Determinants of health-related quality of life in institutionalised older persons in northern Sydney. Internal medicine journal. 2005; 35:131-4. [Abstract]
  • Sambrook, P. How to prevent steroid induced osteoporosis. Annals of the rheumatic diseases. 2005; 64:176-8. [Abstract]
  • Jackson, C., Xue, M., Thompson, P., Davey, R., Whitmont, K., Smith, S., Buisson-Legendre, N., Sztynda, T., Furphy, L., Cooper, A., Sambrook, P., March, L. Activated protein C prevents inflammation yet stimulates angiogenesis to promote cutaneous wound healing. Wound repair and regeneration: official publication of the Wound Healing Society [and] the European Tissue Repair Society. 2005; 13:284-94. [Abstract]
  • Eisman, J., Ebeling, P., Flicker, L., Hearnden, N., Mason, R., Pasco, J., Reid, I., Sambrook, P., Stenmark, J., Wark, J. Recommendations from the vitamin D and calcium forum. Medicine Today. 2005; 6:43-50.
  • Sambrook, P. Vitamin D and fractures: quo vadis?. Lancet. 2005; 365:1599-600. [Abstract]

2004

  
  • Sambrook, P., Chen, J., March, L., Cameron, I., Cumming, R., Lord, S., Schwarz, J., Seibel, M. Serum parathyroid hormone is associated with increased mortality independent of 25-hydroxy vitamin d status, bone mass, and renal function in the frail and very old: a cohort study. The Journal of clinical endocrinology and metabolism. 2004; 89:5477-81. [Abstract]
  • Zochling, J., Nguyen, T., March, L., Sambrook, P. Quantitative ultrasound measurements of bone: measurement error, discordance, and their effects on longitudinal studies. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2004; 15:619-24. [Abstract]
  • MacGregor, A., Andrew, T., Sambrook, P., Spector, T. Structural, psychological, and genetic influences on low back and neck pain: a study of adult female twins. Arthritis and rheumatism. 2004; 51:160-7. [Abstract]
  • Sambrook, P., Geusens, P., Ribot, C., Solimano, J., Ferrer-Barriendos, J., Gaines, K., Verbruggen, N., Melton, M. Alendronate produces greater effects than raloxifene on bone density and bone turnover in postmenopausal women with low bone density: results of EFFECT (Efficacy of FOSAMAX versus EVISTA Comparison Trial) International. Journal of internal medicine. 2004; 255:503-11. [Abstract]
  • Sambrook, P., Chen, J., March, L., Cameron, I., Cumming, R., Lord, S., Zochling, J., Sitoh, Y., Lau, T., Schwarz, J., Seibel, M. Serum parathyroid hormone predicts time to fall independent of vitamin D status in a frail elderly population. The Journal of clinical endocrinology and metabolism. 2004; 89:1572-6. [Abstract]
  • Nowson, C., Diamond, T., Pasco, J., Mason, R., Sambrook, P., Eisman, J. Vitamin D in Australia. Issues and recommendations. Australian family physician. 2004; 33:133-8. [Abstract]
  • Sambrook, P., Rodriguez, J., Wasnich, R., Luckey, M., Kaur, A., Meng, L., Lombardi, A. Alendronate in the prevention of osteoporosis: 7-year follow-up. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2004; 15:483 - 488. [Abstract]

2003

  
  • Hunter, D., Snieder, H., March, L., Sambrook, P. Genetic contribution to cartilage volume in women: a classical twin study. Rheumatology (Oxford, England). 2003; 42:1495-500. [Abstract]
  • Sambrook, P., Hughes, D., Nelson, A., Robinson, B., Mason, R. Osteocyte viability with glucocorticoid treatment: relation to histomorphometry. Annals of the rheumatic diseases. 2003; 62:1215-1217. [Abstract]
  • Lord, S., March, L., Cameron, I., Cumming, R., Schwarz, J., Zochling, J., Chen, J., Makaroff, J., Sitoh, Y., Lau, T., Brnabic, A., Sambrook, P. Differing risk factors for falls in nursing home and intermediate-care residents who can and cannot stand unaided. Journal of the American Geriatrics Society. 2003; 51:1645-50. [Abstract]
  • Hunter, D., March, L., Sambrook, P. The association of cartilage volume with knee pain. Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society. 2003; 11:725-9. [Abstract]
  • Naganathan, V., Sambrook, P. Gender differences in volumetric bone density: a study of opposite-sex twins. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2003; 14:564-9. [Abstract]
  • Briffa, N., Keogh, A., Sambrook, P., Eisman, J. Reduction of immunosuppressant therapy requirement in heart transplantation by calcitriol. Transplantation. 2003; 75:2133-4. [Abstract]
  • Sambrook, P., Kotowicz, M., Nash, P., Styles, C., Naganathan, V., Henderson-Briffa, K., Eisman, J., Nicholson, G. Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2003; 18:919-24. [Abstract]
  • Sambrook, P. Once weekly alendronate. Drugs of today (Barcelona, Spain : 1998). 2003; 39:339-46. [Abstract]
  • Sambrook, P. Glucocorticoid-induced osteoporosis. In: Rheumatology: Third Edition: Volume 2. Edinburgh: Mosby 2003. p. 2109-2116.
  • Parker, D., Hwa, S., Sambrook, P., Ghosh, P. Estrogen replacement therapy mitigates the loss of joint cartilage proteoglycans and bone mineral density induced by ovariectomy and osteoarthritis. Journal Of Rheumatology. 2003; 6:116-127.
  • Wilson, S., Reed, P., Bansal, A., Chiano, M., Lindersson, M., Langdown, M., Prince, R., Thompson, D., Thompson, E., Bailey, M., Kleyn, P., Sambrook, P., Shi, M., Spector, T. Comparison of genome screens for two independent cohorts provides replication of suggestive linkage of bone mineral density to 3p21 and 1036. American Journal Of Human Genetics. 2003; 72:144-155.
  • Sitoh, Y., Lau, T., Zochling, J., Cumming, R., Lord, S., Schwarz, J., March, L., Sambrook, P., Douglas, I. Proxy assessment of health-related quality of life in the frail elderly. Age And Ageing. 2003; 32:459-461.
  • Lau, R., Sambrook, P. Osteoarthritis and osteoporosis - the interface. In: Orthopaedic Issues In Osteoporosis. Boca Raton: CRC Press 2003. p. 513-528.

Current national competitive grants*

2010

A randomised controlled trial to evaluate the effectiveness of zoledronate therapy in osteonecrosis of the hip
Sambrook P, Little D, March L, Buchbinder R
NHMRC Project Grant ($511,426 over 5 years)

2008

Sirtuins and the molecular epidemiology of frailty in older men
Cumming R, Le Couteur D, Kennerson M, De Cabo R, Naganathan V, Sambrook P
NHMRC Project Grant ($468,000 over 2 years)

Prevention of Osteoporosis as a Consequence of Hormone Treatment in Postmenopausal Women
Kilbreath S, Refshauge K, Beith J, Ward L, Simpson J, Sambrook P, Clifton-Bligh P
Cancer Australia Priority-driven Collaborative Cancer Research ($418,950 over 4 years)

Common pathways influencing osteoporosis and atherosclerosis
Sambrook P, Hayward C
NHMRC Project Grant ($426,107 over 3 years)

2006

The FREEDOM Study: A RCT of sunlight and calcium to reduce vitamin D deficiency in older people in residential care
Sambrook P, March L, Cameron I, Cumming R, Seibel M, Simpson J, Mason R
NHMRC Project Grant ($820,300 over 4 years)

* Grants administered through the University of Sydney